Martina Torchio
University of Milan
CancerInternal medicinePathologyOncologyCellIntensive care medicineMaterials scienceImmunologyHazard ratioChemotherapyNeutropeniaMerkel cell carcinomaNeuroendocrine tumorsPrimary tumorPopulationIn patientAdjuvant radiotherapyAdvanced cancerMgmt methylationCancer researchColorectal cancerCirculating tumor cellMedicineGastroenterology
46Publications
8H-index
215Citations
Publications 47
Newest
#1Elena Bolzacchini (University of Insubria)H-Index: 4
#2Monica GiordanoH-Index: 22
Last. Marco DanovaH-Index: 28
view all 13 authors...
Background null Hemochrome parameters at the diagnosis of metastatic renal cell carcinoma (mRCC) and the development of macrocytosis during sunitinib therapy are considered prognostic. null Objective null To evaluate the prognostic role of hematologic parameters and macrocytosis in mRCC treated with sunitinib. null Methods null We analyzed clinical data of 100 patients with mRCC treated with sunitinib as first-line therapy in a retrospective multicenter study. We calculated neutrophil-to-lymphoc...
Source
#1Martina TorchioH-Index: 8
#2Laura CattaneoH-Index: 12
Last. Giulia Bertino (UNIPV: University of Pavia)H-Index: 19
view all 15 authors...
This case report shows, for the first time, a patient experiencing a complete response after one dose of avelumab following extensive disease progression with prior electrochemotherapy (ECT) treatment. We suggest that ECT may help to establish a tumor microenvironment favorable to immunotherapy. Merkel cell carcinoma (MCC) is a highly aggressive skin cancer with seldom durable chemotherapy responses. ECT has recently emerged as a potential treatment option for several malignancies, including MCC...
Source
#1Natalie PrinziH-Index: 12
#2Roberta Elisa Rossi (University of Milan)H-Index: 26
Last. Sara PuscedduH-Index: 18
view all 18 authors...
Neuroendocrine neoplasms of the lung represent about 20% to 30% of all neuroendocrine tumors. On the basis of clinical and pathologic characteristics, 2 different categories of tumors may be defined: poorly differentiated neuroendocrine neoplasms, characterized by a high rate of recurrences and poor prognosis, and well-differentiated neuroendocrine neoplasms (typical carcinoids and atypical carcinoids), which generally display an indolent course. Lung carcinoids represent only 1% to 5% of all lu...
Source
#1S. Partelli (Esso)H-Index: 1
#2Francesco Sclafani (European Organisation for Research and Treatment of Cancer)
Last. Philip Poortmans (European CanCer Organisation)H-Index: 4
view all 23 authors...
Abstract ECCO Essential Requirements for Quality Cancer Care (ERQCC) are written by experts representing all disciplines involved in cancer care in Europe. They give patients, health professionals, managers and policymakers a guide to essential care throughout the patient journey. Pancreatic cancer is an increasing cause of cancer mortality and has wide variation in treatment and care in Europe. It is a major healthcare burden and has complex diagnosis and treatment challenges. Care must be carr...
2 CitationsSource
#1Filippo Pietrantonio (University of Milan)H-Index: 32
#2Federica MoranoH-Index: 21
Last. Maria Di BartolomeoH-Index: 28
view all 25 authors...
Abstract The current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak poses a major challenge in the treatment decision making of cancer patients, who may be at higher risk of developing a severe and deadly SARS-CoV-2 infection compared to the general population. The healthcare emergency is forcing to reshape the daily assessment between risks and benefits expected from the administration of immune-suppressive and potentially toxic treatments. To guide our clinical decisions...
12 CitationsSource
#1Martina TorchioH-Index: 8
#2Francesca CortiH-Index: 6
Last. Sara PuscedduH-Index: 18
view all 20 authors...
Source
One size does not fit all for pancreatic cancers: A review on rare histologies and therapeutic approaches
3 CitationsSource
#1Sara PuscedduH-Index: 18
#2Roberta Elisa RossiH-Index: 26
Last. Filippo de BraudH-Index: 69
view all 18 authors...
Diarrhea is a recurrent symptom in patients with neuroendocrine tumors (NETs) and can represent different etiologies; thus, differential diagnosis is challenging. This paper distinguishes the different causes of chronic diarrhea in patients with gastroenteropancreatic NETs, with the aim to identify the most appropriate therapeutic approach. Underlying causes of diarrhea can be multifactorial, including not only diarrhea that is related to specific hormonal hypersecretory syndromes, but also diar...
5 CitationsSource
#1Sara PuscedduH-Index: 18
#2Francesca CortiH-Index: 6
Last. Filippo de Braud (University of Milan)H-Index: 69
view all 7 authors...
This letter to the editor remarks on recently reported results of the PALBONET study and describes reasons why it may be too early to eliminate CDK4/6 inhibitors as an option for the treatment of neuroendocrine neoplasms.
Source
#1Sara PuscedduH-Index: 18
#2Claudio VernieriH-Index: 17
Last. Filppo de Braud (University of Milan)H-Index: 1
view all 15 authors...
The incidence of pancreatic neuroendocrine tumors (panNETs) has increased worldwide in the last two decades. Given the indolent nature of these tumors, several patients are diagnosed with metastati...
2 CitationsSource